Fujian South Pharmaceutical Co.,Ltd. (FSP) is a GMP approved pharmaceutical manufacturer in China.
FSP was established in September 2001, located in Mingxi county, Fujian province, China.
After 24 years growth, FSP has been developed into the major Oncology API and intermediate manufacturer in China.
The product scope also covers non-oncology API and intermediates as well as Botanic products, by using his state-of-the-art extraction technology and rich production experience.
GMP is the life of our company.  GMP approved by US-FDA, EDQM, COFEPRIS, NMPA.
FSP is a public-listed company. The stock number is 831207.
FSP is the largest professional manufacturer of 10-DAB III, Paclitaxel, Docetaxel in China, with vertical business from Taxus plantation, extraction to synthetic production, ensured a sustainable and stable supply-chain for the whole industry.